Wednesday, September 25, 2019
- 1:15pm-2:45pm
-
The Relationship of Neuropsychiatric Symptoms and Cognitive Impairment in Parkinson’s Disease
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
The relationship of non-motor symptoms with the dominant symptom and the stage of patients with Parkinson’s disease
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
The right hemisphere inhibitory network in patients with asymmetrical Parkinson’s disease: An fMRI study
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
The role of lipid metabolism in mouse models of Parkinson’s disease
Physiology and Pathophysiology · Les Muses, Level 3
- 1:15pm-2:45pm
-
The role of Synaptic vesicle protein 2A (SV2A) in patients with Parkinson’s disease dementia and Dementia with Lewy bodies: An in vivo [11C]UCB-J PET study
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
The social interaction in patients with Parkinson’s disease from the points of activities of daily living and motor function
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
The spectrum of involuntary vocalizations in humans
Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
The Urge to Move in Restless Legs Syndrome Associated with Parkinson’s Disease: A Motor Impulse Control Disorder?
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
The Use of Diffusion Weighted Imaging to Detect Structural Biomarkers in Recently-Diagnosed Parkinson’s Disease Patients
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
The utility of DCTclock™ (the digital clock drawing test) for unmasking early cognitive decline in Parkinson’s disease
Cognition and Cognitive Disorders · Agora 3 East, Level 3
- «Previous Page
- 1
- …
- 60
- 61
- 62
- 63
- 64
- …
- 67
- Next Page»